Pharvaris
Latest round
- Series C
Last raised
- Nov 2020
Total raised
- $162M
Investors
- 10
About Pharvaris
Founded in 2015 and based in Zug, Switzerland, Pharvaris GmbH operates as a clinical-stage biotechnology company that develops therapeutic orally-taken drugs for HAE (hereditary angioedema). In November 2020, Pharvaris GmbH filed for an IPO (Initial Public Offering) prospectus.27 million shares at USD 20 per share on the NASDAQ. The company's medical R&D team focuses on bringing orally bioavailable small-molecule bradykinin B2-receptor antagonists to the market and treat HAE patients and other B2 receptor-mediated indications. The product pipeline includes PHA121 solution, PHVS416 soft capsule, and PHVS719 tablet. Pharvaris GmbH also offers RAPIDe-1, a clinical research study to determine the effectiveness of three different doses of the study drug in relieving symptoms associated with HAE attacks.
Who invested in Pharvaris
10 investors across 3 rounds
See all investors in Pharvaris
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pharvaris
Who invested in Pharvaris?
Pharvaris has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pharvaris raised?
Pharvaris has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Pharvaris last raise money?
Pharvaris's most recent round on record is a Series C, in Nov 2020.
What does Pharvaris do?
Founded in 2015 and based in Zug, Switzerland, Pharvaris GmbH operates as a clinical-stage biotechnology company that develops therapeutic orally-taken drugs for HAE (hereditary angioedema).
Where is Pharvaris headquartered?
Pharvaris is headquartered in Zug, Switzerland.
Which VCs invest in companies like Pharvaris?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Pharvaris's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Pharvaris? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.